Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors

Background: We have recommended active surveillance as the preferred management option for clinical stage I (CSI) testicular germ cell tumors (GCTs) since 1980. Over time, the recommended intensity of surveillance has decreased; however, the impact on relapse detection has not been investigated. Obj...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peter J. Gariscsak, Lynn Anson-Cartwright, Eshetu G. Atenafu, Di Maria Jiang, Peter Chung, Philippe Bedard, Padraig Warde, Martin O'Malley, Joan Sweet, Rachel M. Glicksman, Robert J. Hamilton
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2022-06-01
Col·lecció:European Urology Open Science
Matèries:
Cancer outcomes
Radiation exposure
Surveillance
Testicular neoplasms
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2666168322000635
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars